Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saad J. Kenderian
Observed names:
S. J. Kenderian,
S. Kenderian
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5042678113
Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review
2021
·
Hadir Shakshouk
, Eric R. Tkaczyk
, et al.
·
Transplantation and Cellular Therapy
·
12
Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient
2018
·
Jesus Vera-Aguilera
, Narjust Duma
, et al.
·
Mayo Clinic Proceedings Innovations Quality & Outcomes
·
6
PDF
Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin
2018
·
J. S. Lehman
, S. Dasari
, et al.
·
Clinical and Experimental Dermatology
·
5
Abstract 1525: Optimized CART cell therapy to remodel the tumor microenvironment and eliminate GI malignancies
2026
·
Omar L. Gutierrez Ruiz
, Jennifer Feigin
, et al.
·
Cancer Research
·
1
024 Differentiation of acute graft-versus-host disease from drug reaction in skin by a novel tissue-based biomarker assay
2019
·
J.S. Lehman
, S. Dasari
, et al.
·
Journal of Investigative Dermatology
·
1
PDF
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population
2026
·
Lauren D. Pomerantz
, Kari G. Rabe
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Abstract 1213: Mitochondrial transcriptome profiles associated with clinical responses to CAR-T therapy in aggressive lymphoma.
2026
·
Jacqueline Turner
, Panwen Wang
, et al.
·
Cancer Research
Abstract 3278: Metabolic pathway signatures defining response to CD19 CAR T-Cell therapy in aggressive B-cell non-hodgkin lymphoma
2026
·
Melinda S.Y. Tan
, Panwen Wang
, et al.
·
Cancer Research
Abstract 4228: Validation of the CLL treatment infection model (CLL-TIM) in patients with newly diagnosed chronic lymphocytic leukemia (CLL)
2026
·
Raphael Mwangi
, Tait D. Shanafelt
, et al.
·
Cancer Research
Withdrawn: Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter Transformation (RT) and Chronic Lymphocytic Leukemia (CLL)
2024
·
Shulan Tian
, Hanyin Wang
, et al.
·
Preprints.org
P1094: Characteristics, Management, and Outcomes of Patients With T-cell Large Granular Lymphocytic Leukemia at a Large Tertiary Care Center
2022
·
H. Audil
, M. Shah
, et al.
·
HemaSphere
Author response for "Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome"
2021
·
Hanyin Wang
, Shulan Tian
, et al.
Abstract 6466: Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)
2020
·
Sameer A. Parikh
, Cristine Allmer
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
25
H-index:
3
I10-index:
1
Year
Topic
Type